Related references
Note: Only part of the references are listed.Population pharmacokinetics of roxadustat in Japanese dialysis-dependent chronic kidney disease patients with anaemia
Akitsugu Takada et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease
Dinko Rekic et al.
CLINICAL PHARMACOKINETICS (2021)
Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
Dorien Groenendaal-van de Meent et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2021)
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label Study
Tadao Akizawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2020)
Oral roxadustat three times weekly in ESA-naive and ESA-converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies
Tadao Akizawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2020)
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Tadao Akizawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Bayesian K-PD model for synergy: A case study
Fabiola La Gamba et al.
PHARMACEUTICAL STATISTICS (2018)
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
Makoto Kinoshita et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Hypoxia-inducible factor 1α activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver
Seonghwan Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice
Marleen Schonewille et al.
JOURNAL OF LIPID RESEARCH (2016)
Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records
Makoto Kakara et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Effects of Switching From Sevelamer Hydrochloride to Bixalomer on Laboratory Parameters in Hemodialysis Patients
Kazunori Furukawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2014)
Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients
Masatomo Taniguchi et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2013)
A Population Pharmacokinetic-Pharmacodynamic Model for Simvastatin that Predicts Low-Density Lipoprotein-Cholesterol Reduction in Patients with Primary Hyperlipidaemia
Jimyon Kim et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
C. Baigent et al.
AMERICAN HEART JOURNAL (2010)
Cardiovascular Death in Dialysis Patients: Lessons We Can Learn from AURORA
Allan D. Sniderman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Derivation of various NONMEM estimation methods
Yaning Wang
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs
Andrew D. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Modelling response time profiles in the absence of drug concentrations: Definition and performance evaluation of the K-PD model
P. Jacqmin et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Share Paper
